CHOICE:Decision Factor of EGFR-TKI in Chinese IV NSCLC
Recruiting
Observational Study
Non-Small Cell Lung Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
590 (estimated)
Sponsor
AstraZeneca · Industry
Who this trial is looking for
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
This non-interventional, cross-sectional study aims to investigate treatment preferences from a sample of physicians and patients with experience of 1L EGFR-TKI for stage IV NSCLC by administering a survey, which primarily includes a DCE approach.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
The following inclusion criteria must be met in order to be enrolled in the stage 1:
Patient:
* Provide informed consent
* 18 years or older
* Diagnosed with stage IV NSCLC
* Currently receiving or previously received 1L EGFR-TKI treatment
* Without communication barrier
* Do …
Inclusion Criteria:
The following inclusion criteria must be met in order to be enrolled in the stage 1:
Patient:
* Provide informed consent
* 18 years or older
* Diagnosed with stage IV NSCLC
* Currently receiving or previously received 1L EGFR-TKI treatment
* Without communication barrier
* Do not exhibit signs of cognitive impairment that would prevent participation in an interview, as informally assessed during screening by the recruiter
Physician:
* Provide informed consent
* Specialized in departments of medical oncology, respiratory medicine, or thoracic surgery at tertiary hospitals
* Manage at least 3 stage IV NSCLC patients with 1L EGFR-TKI per month
* Holding the title of associate chief physician or higher
The following inclusion criteria must be met in order to be enrolled in the stage 2:
Patient:
* Provide informed consent
* 18 years or older
* Diagnosed with stage IV NSCLC
* Currently receiving or previously received 1L EGFR-TKI treatment
* Without communication barrier
* Do not exhibit signs of cognitive impairment that would prevent participation in a survey, as informally assessed during screening by the recruiter
Physician:
* Provide informed consent
* Specialized in departments of medical oncology, respiratory medicine, or thoracic surgery at tertiary hospitals
* Manage at least 3 stage IV NSCLC patients with 1L EGFR-TKI per month
* Holding the title of attending physician or higher
Exclusion Criteria:
Not applicable.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.